UPR was activated in later stage V patients diagnosed with early onset AD (EAD) and AD patients in stage VI, as reflected by marked hyperactivation of PERK and eIF2α (Fig 1E and 1F). This evidence concerns the gene EIF2AK3 and Alzheimer disease.